Literature DB >> 1116882

Cell-mediated immunity to insulin and its polypeptide chains in insulin-treated diabectics.

W P Faulk, J P Girard, H D Welscher.   

Abstract

35 insulin-treated diabetics and 25 control persons were studied for in vivo and in vitro manifestations of hypersensitivity to insulin and its isolated polypeptide chains. Delayed hypersensitivity reactions were determined by skin testing, and blastogenic conversion tests were done with peripheral blood lymphocytes. None of the controls and 62.9% of the patients gave positive reactions in the blastogenic test, most of these reacted to the intact molecule, fewer patients responded to B chains, and very few responded to A chains. None of the controls and only three of the patients produced positive delayed hypersensitivity reactions to insulin, and all of these were to the intact insulin molecule.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116882     DOI: 10.1159/000231321

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  Cellular cytotoxicity to membrane-associated insulin in an autologous system.

Authors:  E R Richens; M E Seward; R W Groves
Journal:  Acta Diabetol Lat       Date:  1985 Jan-Mar

2.  Lymphocyte transformation by insulin and insulin-zinc suspensions.

Authors:  P Diem; H Spengler; A L de Weck
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

Review 3.  Fetoplacental physiology in relation to metabolic diseases.

Authors:  W P Faulk
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

4.  The human cellular immune response to insulin: a study in unexposed control subjects and type I diabetic patients on acute and chronic treatment.

Authors:  E R Richens; M E Seward; W A Luqman; M Hartog
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

5.  Insulin responses and lymphocyte subclasses in children with newly diagnosed insulin-dependent diabetes.

Authors:  T Scheinin; J Mäenpää; S Koskimies; B M Dean; G F Bottazzo; S Kontiainen
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.